The U.S. Food and Drug Administration sent warning letters
to four drug companies, saying their promotional materials for four drugs make inaccurate or incomplete statements. The FDA demanded that Bayer, Eli Lilly (LLY
), Cephalon (CEPH
) and Amylin Pharmaceuticals (AMLN
) stop using ads the agency says exaggerate the efficacy of a drug or downplay its risks.